Novo Nordisk A/S (NVO)

Last Closing Price: 65.16 (2025-04-29)

EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Novo Nordisk A/S (NVO) had EBITDA of $5.97B for the most recently reported fiscal quarter, ending 2024-12-31.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
$12.26B
$4.03B
$1.86B
$10.40B
$7.02B
$5.24B
$-172.91M
$5.07B
$5.07B
$4.03B
$4.03B
$4.03B
$4.03B
$5.24B
EBITDA
$5.97B
4.45B
4.46B
$0.90
$0.90
Balance Sheet Financials
$23.33B
$23.56B
$44.21B
$67.54B
$31.54B
$13.00B
$15.19B
$46.73B
$20.81B
$4.70B
$20.81B
4.46B
Cash Flow Statement Financials
$17.54B
$-18.69B
$1.27B
$2.09B
$2.27B
$183.13M
$331.90M
$-6.40B
--
Fundamental Metrics & Ratios
0.74
--
--
0.38
0.72
84.81%
42.77%
42.77%
--
41.36%
32.84%
$10.70B
--
--
--
0.18
0.31
0.97
93.04
19.35%
85.72%
5.96%
11.91%
$4.66
$2.40
$3.93